The emergence of new appetite-suppressing drugs like Ozempic and Wegovy has revolutionized obesity treatment, transforming it into an exciting medical field. These drugs not only promote significant weight loss but also confer health benefits that exceed mere weight management, including reducing the risk of numerous diseases. Presented at the recent European Congress on Obesity, the drugs work by mimicking hormones that affect appetite regulation. Their rapid success marks a significant turning point in obesity treatment, a field previously overlooked by medicine.
Obesity was once medicine's Cinderella subject with some questioning whether the condition should even be viewed as a biological disorder.
These drugs have energized the field and it has happened so fast. It's become the most scientifically exciting and commercially lucrative area of healthcare.
The benefits of being at a healthy weight are substantial, with weight-loss jabs potentially reducing the risk of 42 diseases including heart disease and cancer.
First developed to help lower blood sugar levels, Novo Nordisk's drug semaglutide has a dramatic effect on weight by mimicking a hormone released in the gut.
Collection
[
|
...
]